These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16900769)

  • 1. Aphasia and multiple sclerosis.
    Habek M
    Mult Scler; 2006 Aug; 12(4):518; author reply 519-20. PubMed ID: 16900769
    [No Abstract]   [Full Text] [Related]  

  • 2. Crossed aphasia in multiple sclerosis.
    Demirkiran M; Ozeren A; Sönmezler A; Bozdemir H
    Mult Scler; 2006 Feb; 12(1):116-9. PubMed ID: 16459730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors determining quality of life in patients with remitting multiple sclerosis].
    Popova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):77-80. PubMed ID: 18567195
    [No Abstract]   [Full Text] [Related]  

  • 4. Color-code agreement among stratus, cirrus, and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis with and without prior optic neuritis.
    Rebolleda G; González-López JJ; Muñoz-Negrete FJ; Oblanca N; Costa-Frossard L; Álvarez-Cermeño JC
    Am J Ophthalmol; 2013 May; 155(5):890-7. PubMed ID: 23398979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyarteritis nodosa with central nervous system involvement mimicking relapsing-remitting multiple sclerosis.
    Ueno K; Matsushima A; Hineno A; Fukushima K; Tazawa K; Matsuda M; Ikeda S
    Mod Rheumatol; 2014 May; 24(3):525-8. PubMed ID: 24506572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enigmatic illness and death of Constance, wife of Oscar Wilde.
    Robins AH; Holland M
    Lancet; 2015 Jan; 385(9962):21-2. PubMed ID: 25592892
    [No Abstract]   [Full Text] [Related]  

  • 8. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
    Gracien R; Kordulla M; Ziemann U
    Mult Scler; 2011 Apr; 17(4):498-500. PubMed ID: 21148018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute left ventricular dysfunction in multiple sclerosis.
    Toniolo M; Bergamini C; Ferrero V; Morando G; Cicoira M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):501-5. PubMed ID: 21085002
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute exacerbation of multiple sclerosis presenting with facial metamorphopsia and palinopsia.
    Anbarasan D; Howard J
    Mult Scler; 2013 Mar; 19(3):369-71. PubMed ID: 22723575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of certain static stabilometric characteristics].
    Likhachev SA; Kachinskiĭ AN
    Vestn Otorinolaringol; 2011; (2):33-7. PubMed ID: 21512483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
    Jurić S; Mišmaš A; Mihić N; Barać AM; Habek M
    Intern Med; 2012; 51(9):1121-4. PubMed ID: 22576400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic and prognostic potential of MRI in multiple sclerosis].
    Pronin IN; Beliaeva IA; Boĭko AN; Kornienko VN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):18-24. PubMed ID: 12938630
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
    Flachenecker P; Meissner H
    Mult Scler; 2008 Mar; 14(2):274-7. PubMed ID: 18337428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pearls: multiple sclerosis.
    Frohman EM; Greenberg BM
    Semin Neurol; 2010 Feb; 30(1):97-101. PubMed ID: 20127590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate endpoints for EDSS worsening in multiple sclerosis: a meta-analytic approach: measuring disability in relapsing-remitting MS.
    Ebers GC; Daumer M; Scalfari A
    Neurology; 2011 Mar; 76(11):1025; author reply 1025-6. PubMed ID: 21403116
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
    Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of self-assessed fatigue and alertness in multiple sclerosis.
    Weinges-Evers N; Brandt AU; Bock M; Pfueller CF; Dörr J; Bellmann-Strobl J; Scherer P; Urbanek C; Boers C; Ohlraun S; Zipp F; Paul F
    Mult Scler; 2010 Sep; 16(9):1134-40. PubMed ID: 20610494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the Swanton multiple sclerosis criteria for dissemination in space.
    Nielsen JM; Uitdehaag BM; Korteweg T; Barkhof F; Polman CH
    Mult Scler; 2010 Aug; 16(8):985-7. PubMed ID: 20547588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiology and disease course of total aphasia].
    Mattes K; Leischner A
    Folia Phoniatr (Basel); 1978; 30(1):13-21. PubMed ID: 631669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.